實德環球(00487.HK)中期收益約5450萬港元 同比增加約54%
格隆匯8月30日丨 實德環球(00487.HK)公吿,截至2022年6月30日止6個月,集團的收益約為港幣5450萬元,同比增加約54%。公司股東應占虧損增加約1.4倍至約港幣1.255億元(2021年:約港幣5280萬元),而每股虧損為2.55港仙(2021年:1.07港仙)。公司董事不建議就截至2022年6月30日止6個月派付中期股息(2021年:無)。
儘管集團應占聯營公司虧損減少,惟集團截至2022年6月30日止6個月未經審核綜合虧損增加,主要源於集團海外上市股本證券未變現公平值虧損大幅增加。該未變現公平值虧損屬非現金項目,並不會影響集團的現金流。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.